These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 39470509)

  • 1. Metformin: Diverse molecular mechanisms, gastrointestinal effects and overcoming intolerance in type 2 Diabetes Mellitus: A review.
    Mohamed S
    Medicine (Baltimore); 2024 Oct; 103(43):e40221. PubMed ID: 39470509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus.
    Foretz M; Guigas B; Viollet B
    Nat Rev Endocrinol; 2019 Oct; 15(10):569-589. PubMed ID: 31439934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of metformin action: In and out of the gut.
    Minamii T; Nogami M; Ogawa W
    J Diabetes Investig; 2018 Jul; 9(4):701-703. PubMed ID: 29777629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into the anti-diabetic actions of metformin: from the liver to the gut.
    Wu T; Horowitz M; Rayner CK
    Expert Rev Gastroenterol Hepatol; 2017 Feb; 11(2):157-166. PubMed ID: 27983877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the gastrointestinal tract to treat type 2 diabetes.
    Bauer PV; Duca FA
    J Endocrinol; 2016 Sep; 230(3):R95-R113. PubMed ID: 27496374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin and the gastrointestinal tract.
    McCreight LJ; Bailey CJ; Pearson ER
    Diabetologia; 2016 Mar; 59(3):426-35. PubMed ID: 26780750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding and overcoming metformin gastrointestinal intolerance.
    Bonnet F; Scheen A
    Diabetes Obes Metab; 2017 Apr; 19(4):473-481. PubMed ID: 27987248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin: old friend, new ways of action-implication of the gut microbiome?
    Rodriguez J; Hiel S; Delzenne NM
    Curr Opin Clin Nutr Metab Care; 2018 Jul; 21(4):294-301. PubMed ID: 29634493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin and gut microbiota: their interactions and their impact on diabetes.
    Vallianou NG; Stratigou T; Tsagarakis S
    Hormones (Athens); 2019 Jun; 18(2):141-144. PubMed ID: 30719628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin-induced changes of the gut microbiota in patients with type 2 diabetes mellitus: results from a prospective cohort study.
    Gao Y; Zhao T; Lv N; Liu S; Yuan T; Fu Y; Zhao W; Zhu B
    Endocrine; 2024 Sep; 85(3):1178-1192. PubMed ID: 38761345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Relationship between the Gut Microbiome and Metformin as a Key for Treating Type 2 Diabetes Mellitus.
    Lee CB; Chae SU; Jo SJ; Jerng UM; Bae SK
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleiotropic effects of metformin: Shaping the microbiome to manage type 2 diabetes and postpone ageing.
    Prattichizzo F; Giuliani A; Mensà E; Sabbatinelli J; De Nigris V; Rippo MR; La Sala L; Procopio AD; Olivieri F; Ceriello A
    Ageing Res Rev; 2018 Dec; 48():87-98. PubMed ID: 30336272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of glucagon-like peptide-1 in the glucose-lowering effect of metformin.
    Bahne E; Hansen M; Brønden A; Sonne DP; Vilsbøll T; Knop FK
    Diabetes Obes Metab; 2016 Oct; 18(10):955-61. PubMed ID: 27265206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic modelling of the human gut microbiome in type 2 diabetes patients in response to metformin treatment.
    Ezzamouri B; Rosario D; Bidkhori G; Lee S; Uhlen M; Shoaie S
    NPJ Syst Biol Appl; 2023 Jan; 9(1):2. PubMed ID: 36681701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of gut microbiota in obesity, diabetes mellitus, and effect of metformin: new insights into old diseases.
    Pascale A; Marchesi N; Govoni S; Coppola A; Gazzaruso C
    Curr Opin Pharmacol; 2019 Dec; 49():1-5. PubMed ID: 31015106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oral metformin on gut microbiota characteristics and metabolite fractions in normal-weight type 2 diabetic mellitus patients.
    Niu X; Wang Y; Huang L; Guo P; Zhang S; Sun Y; Jin M
    Front Endocrinol (Lausanne); 2024; 15():1397034. PubMed ID: 39257903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota of patients with type 2 diabetes and gastrointestinal intolerance to metformin differs in composition and functionality from tolerant patients.
    Díaz-Perdigones CM; Muñoz-Garach A; Álvarez-Bermúdez MD; Moreno-Indias I; Tinahones FJ
    Biomed Pharmacother; 2022 Jan; 145():112448. PubMed ID: 34844104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prebiotic Mannan-Oligosaccharides Augment the Hypoglycemic Effects of Metformin in Correlation with Modulating Gut Microbiota.
    Zheng J; Li H; Zhang X; Jiang M; Luo C; Lu Z; Xu Z; Shi J
    J Agric Food Chem; 2018 Jun; 66(23):5821-5831. PubMed ID: 29701959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of metformin - An update.
    Glossmann HH; Lutz OMD
    Eur J Pharmacol; 2019 Dec; 865():172782. PubMed ID: 31705902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interplay between gut microbiota and tryptophan metabolism in type 2 diabetic mice treated with metformin.
    Xie Y; Li X; Meng Q; Li J; Wang X; Zhu L; Wang W; Li X
    Microbiol Spectr; 2024 Oct; 12(10):e0029124. PubMed ID: 39162538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.